Tag Archives: clinical trials

Farletuzumab Trial Fails to Show Increase in PFS

A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival. See a new article here

Posted in News | Also tagged , , | Leave a comment

Pap Test for Ovarian Cancer?

A small study of 46 women showed that examining cells on the cervix can help identify ovarian and uterine cancers. In this study, DNA analysis detected 41% of ovarian cancer … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

EU Approves Avastin in Combination Therapy for Recurrent Ovarian Cancer

The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer. See the article here

Posted in News | Also tagged , , , | Leave a comment

NIH to Enforce Public Access Policy

As a condition of receiving public monies for research, the researchers must make available the results of their work. The National Institutes of Health will begin to delay grants to … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Intake Question Related to Ovarian Cancer Symptoms Can Help Women Get Diagnosed Sooner

According to a study done by the Fred Hutchison Cancer Cancer, a quick three-question survey as part of patient intake can help women with the symptoms of ovarian cancer be … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Dose Dense Therapy Appears Beneficial

A study of 637 Japanese women with ovarian, fallopian or primary peritoneal cancer showed that dose dense chemotherapy provided a benefit. The standard of care arm provided chemotherapy every three … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Fertility Drugs Do Not Appear to Cause Ovarian Cancer

A study of approximately 2700 women showed that women who used fertility drugs did not have a higher risk of ovarian cancer, except for women who used fertility drugs and … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Fasting Before Chemotherapy?

There is a growing body of data indicating that fasting before chemotherapy renders cancer cells more sensitive to the toxic effects of those drugs. On the other side of the … Continue reading 

Posted in News | Also tagged , , , , , , , , | Leave a comment

An Update on PARP Inhibitors

Development of PARP inhibitors, which appear to work best in women with BRCA mutations, has faced setbacks recently. An article reviews the data, good and bad, about PARP inhibitors. The … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Depo-Provera Shown to Reduce Risk of Ovarian Cancer

A large body of data shows that use of oral contraceptives reduces the risk of developing ovarian cancer. A new study of approximate 1400 women in Thailand suggests that the … Continue reading 

Posted in News | Also tagged , , | Leave a comment

Phase III Trial of Bevacizumab with Chemotherapy

A Phase III trial of bevacizumab (Avastin) with gemcitabine + carboplatin versus gemcitabine + carboplatin in women with ovarian cancer showed the bevacizumab arm to improve progression free survival (PFS). … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Olaparib shows improvement in PFS but not OS, Thus Far

Olaparib, a PARP inhibitor, showed an 3.6 month improvement in progression free survival (PFS) in women with platinum sensitive recurrent ovarian cancer. However, based on the interim analsis, there is … Continue reading 

Posted in News | Also tagged , , , | Leave a comment